Literature DB >> 22366441

Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: Initial analysis.

Jacobus F A Jansen1, Diane L Carlson, Yonggang Lu, Hilda E Stambuk, Andre L Moreira, Bhuvanesh Singh, Snehal G Patel, Dennis H Kraus, Richard J Wong, Ashok R Shaha, Jatin P Shah, Amita Shukla-Dave.   

Abstract

The aim of the present study is to correlate non-invasive, pretreatment biological imaging (dynamic contrast enhanced-MRI [DCE-MRI] and proton magnetic resonance spectroscopy [(1)H-MRS]) findings with specific molecular marker data in neck nodal metastases of head and neck squamous cell carcinoma (HNSCC) patients. Pretreatment DCE-MRI and (1)H-MRS were performed on neck nodal metastases of 12 patients who underwent surgery. Surgical specimens were analyzed with immunohistochemistry (IHC) assays for: Ki-67 (reflecting cellular proliferation), vascular endothelial growth factor (VEGF) (the "endogenous marker" of tumor vessel growth), carbonic anhydrase (CAIX), hypoxia inducible transcription factor (HIF-1α), and human papillomavirus (HPV). Additionally, necrosis was estimated based on H&E staining. The Spearman correlation was used to compare DCE-MRI, (1)H-MRS, and molecular marker data. A significant correlation was observed between DCE-MRI parameter std(k(ep)) and VEGF IHC expression level (rho=0.81, p=0.0001). Furthermore, IHC expression levels of Ki-67 inversely correlated with std(K(trans)) and std(v(e)) (rho=-0.71; p=0.004, and rho=-0.73; p=0.003, respectively). Other DCE-MRI, (1)H-MRS and IHC values did not show significant correlation. The results of this preliminary study indicate that the level of heterogeneity of perfusion in metastatic HNSCC seems positively correlated with angiogenesis, and inversely correlated with proliferation. These results are preliminary in nature and are indicative, and not definitive, trends portrayed in HNSCC patients with nodal disease. Future studies with larger patient populations need to be carried out to validate and clarify our preliminary findings.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366441      PMCID: PMC3368067          DOI: 10.1016/j.oraloncology.2012.02.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  32 in total

1.  VEGF and ki 67 expression in squamous cell carcinoma of the tongue: An immunohistochemical and computerized image analysis study.

Authors:  Gregory Faratzis; Evangelos Tsiambas; Alexander D Rapidis; Aggeliki Machaira; Konstantinos Xiromeritis; Efstratios Patsouris
Journal:  Oral Oncol       Date:  2008-09-18       Impact factor: 5.337

2.  Predictive value of P53, BCL-2, and BAX in advanced head and neck carcinoma.

Authors:  Susana Casado; Jerónimo Forteza; Severina Dominguez; M Teresa Abad; Isabel Perez; Iratxe Intxaurbe; J M del Campo; Rafael Lopez
Journal:  Am J Clin Oncol       Date:  2002-12       Impact factor: 2.339

3.  Differential biomarker expression in head and neck cancer correlates with anatomical localization.

Authors:  László Tamás; Gabriella Szentkúti; Mónika Eros; Kornél Dános; Diána Brauswetter; Béla Szende; Ivett Zsákovics; Tibor Krenács
Journal:  Pathol Oncol Res       Date:  2011-04-13       Impact factor: 3.201

Review 4.  Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma.

Authors:  Jacobus F A Jansen; Jason A Koutcher; Amita Shukla-Dave
Journal:  Angiogenesis       Date:  2010-04-11       Impact factor: 9.596

Review 5.  Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker.

Authors:  Nola Hylton
Journal:  J Clin Oncol       Date:  2006-07-10       Impact factor: 44.544

6.  Correlation of biomarkers in head and neck squamous cell carcinoma.

Authors:  Gary M Tse; Ann D King; Alex M C Yu; Christopher C F Lam; Anthony W H Chan; George G Chen; David K Yeung; Kwok-Hung Yu; Kunwar S Bhatia; Amy B W Chan
Journal:  Otolaryngol Head Neck Surg       Date:  2010-12       Impact factor: 3.497

7.  Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.

Authors:  Quido G de Lussanet; Walter H Backes; Arjan W Griffioen; Anwar R Padhani; Coen I Baeten; Angela van Baardwijk; Philippe Lambin; Geerard L Beets; Jos M A van Engelshoven; Regina G H Beets-Tan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-26       Impact factor: 7.038

8.  Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

Authors:  Oriol Casanovas; Daniel J Hicklin; Gabriele Bergers; Douglas Hanahan
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

Review 9.  Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis.

Authors:  Peter Vaupel
Journal:  Oncologist       Date:  2008

Review 10.  Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols.

Authors:  P S Tofts; G Brix; D L Buckley; J L Evelhoch; E Henderson; M V Knopp; H B Larsson; T Y Lee; N A Mayr; G J Parker; R E Port; J Taylor; R M Weisskoff
Journal:  J Magn Reson Imaging       Date:  1999-09       Impact factor: 4.813

View more
  22 in total

1.  Texture analysis on parametric maps derived from dynamic contrast-enhanced magnetic resonance imaging in head and neck cancer.

Authors:  Jacobus Fa Jansen; Yonggang Lu; Gaorav Gupta; Nancy Y Lee; Hilda E Stambuk; Yousef Mazaheri; Joseph O Deasy; Amita Shukla-Dave
Journal:  World J Radiol       Date:  2016-01-28

2.  Dynamic contrast-enhanced MRI of oral squamous cell carcinoma: a preliminary study of the correlations between quantitative parameters and the clinical stage.

Authors:  T Chikui; E Kitamoto; Y Kami; S Kawano; K Kobayashi; T Kamitani; M Obara; K Yoshiura
Journal:  Br J Radiol       Date:  2015-04-23       Impact factor: 3.039

Review 3.  Review of the clinical and biologic aspects of human papillomavirus-positive squamous cell carcinomas of the head and neck.

Authors:  Grace C Blitzer; Molly A Smith; Stephen L Harris; Randall J Kimple
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-03-15       Impact factor: 7.038

4.  Arterial spin labeling perfusion-weighted MR imaging: correlation of tumor blood flow with pathological degree of tumor differentiation, clinical stage and nodal metastasis of head and neck squamous cell carcinoma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Nadia Nada
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-03-27       Impact factor: 2.503

Review 5.  Functional magnetic resonance imaging techniques and their development for radiation therapy planning and monitoring in the head and neck cancers.

Authors:  Jing Yuan; Gladys Lo; Ann D King
Journal:  Quant Imaging Med Surg       Date:  2016-08

6.  Soft tissue sarcoma: DWI and DCE-MRI parameters correlate with Ki-67 labeling index.

Authors:  Ji Hyun Lee; Young Cheol Yoon; Sung Wook Seo; Yoon-La Choi; Hyun Su Kim
Journal:  Eur Radiol       Date:  2019-10-18       Impact factor: 5.315

Review 7.  Proton magnetic resonance spectroscopy in oncology: the fingerprints of cancer?

Authors:  Roberto García-Figueiras; Sandra Baleato-González; Anwar R Padhani; Laura Oleaga; Joan C Vilanova; Antonio Luna; Juan Carlos Cobas Gómez
Journal:  Diagn Interv Radiol       Date:  2016 Jan-Feb       Impact factor: 2.630

Review 8.  Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.

Authors:  S Gaddikeri; R S Gaddikeri; T Tailor; Y Anzai
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-01       Impact factor: 3.825

Review 9.  Modulation of therapeutic sensitivity by human papillomavirus.

Authors:  Adam D Swick; Anirban Chatterjee; Anna-Maria A De Costa; Randall J Kimple
Journal:  Radiother Oncol       Date:  2015-09-10       Impact factor: 6.280

10.  Early posttreatment assessment of MRI perfusion biomarkers can predict long-term response of lung cancer brain metastases to stereotactic radiosurgery.

Authors:  Neil K Taunk; Jung Hun Oh; Amita Shukla-Dave; Kathryn Beal; Behroze Vachha; Andrei Holodny; Vaios Hatzoglou
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.